Innate Pharma S.A. (IPHA)
NasdaqGS - NasdaqGS Delayed price. Currency in USD
Add to watchlist
As of 04:00PM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 186.53M |
| Enterprise value | 130.51M |
| Trailing P/E | 13.66 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 3.52 |
| Price/book (mrq) | 3.54 |
| Enterprise value/revenue | 2.51 |
| Enterprise value/EBITDA | -70.97 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.67 |
| 52-week change 3 | -15.51% |
| S&P500 52-week change 3 | 23.06% |
| 52-week high 3 | 3.5700 |
| 52-week low 3 | 1.8100 |
| 50-day moving average 3 | 2.5355 |
| 200-day moving average 3 | 2.6615 |
Share statistics
| Avg vol (3-month) 3 | 10.85k |
| Avg vol (10-day) 3 | 10.79k |
| Shares outstanding 5 | 80.84M |
| Implied shares outstanding 6 | 83.67M |
| Float 8 | 30.66M |
| % held by insiders 1 | 0.00% |
| % held by institutions 1 | 0.14% |
| Shares short (28 Mar 2024) 4 | 76.87k |
| Short ratio (28 Mar 2024) 4 | 6.87 |
| Short % of float (28 Mar 2024) 4 | N/A |
| Short % of shares outstanding (28 Mar 2024) 4 | 0.10% |
| Shares short (prior month 29 Feb 2024) 4 | 78.36k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Currency in EUR.Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -12.28% |
| Operating margin (ttm) | -57.22% |
Management effectiveness
| Return on assets (ttm) | -4.04% |
| Return on equity (ttm) | -14.28% |
Income statement
| Revenue (ttm) | 61.64M |
| Revenue per share (ttm) | 0.77 |
| Quarterly revenue growth (yoy) | 77.40% |
| Gross profit (ttm) | N/A |
| EBITDA | -7.58M |
| Net income avi to common (ttm) | -7.57M |
| Diluted EPS (ttm) | -0.1000 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 92.46M |
| Total cash per share (mrq) | 1.14 |
| Total debt (mrq) | 39.89M |
| Total debt/equity (mrq) | 76.86% |
| Current ratio (mrq) | 3.73 |
| Book value per share (mrq) | 0.64 |
Cash flow statement
| Operating cash flow (ttm) | -32.56M |
| Levered free cash flow (ttm) | -27.07M |
© 2024 Yahoo. All rights reserved.